Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280554970> ?p ?o ?g. }
- W4280554970 endingPage "1810" @default.
- W4280554970 startingPage "1794" @default.
- W4280554970 abstract "Background & Aim Hydrogen sulfide (H2S) plays a protective role in non-alcoholic fatty liver disease (NAFLD). However, whether cystathionine gamma lyase (CSE), a dominant H2S generating enzyme in hepatocytes, has a role in the pathogenesis of NAFLD is currently unclear. Approach & Results We showed that CSE protein expression is dramatically down-regulated, especially in fibrotic areas, in livers from NAFLD patients. In high fat diet (HFD)-induced NAFLD mice, or an oleic acid-induced hepatocyte model, the CSE/H2S pathway is also down-regulated. To illustrate a regulatory role for CSE in NAFLD, we generated a hepatocyte-specific CSE knockout mouse (CSELKO). Feeding a HFD to CSELKO mice, they showed more hepatic lipid deposition with increased activity of the fatty acid de-novo synthesis pathway, increased hepatic insulin resistance and higher hepatic gluconeogenic ability, compared to CSELoxp control mice. By contrast, H2S donor treatment attenuated these phenotypes. Furthermore, the protection conferred by H2S was blocked by Farnesoid X receptor (FXR) knockdown. Consistently, serum deoxycholic acid and lithocholic acid (FXR antagonists) were increased, and tauro-β-muricholic acid (FXR activation elevated) was reduced in CSELKO. CSE/H2S promoted a novel post-translation modification (sulfhydration) of FXR at Cys138/141 sites, thereby enhancing its activity to modulate expression of target genes related to lipid and glucose metabolism, inflammation, and fibrosis. Sulfhydration proteomics in patient’s liver supported the CSE/H2S modulation noted in the CSELKO mice. Conclusion FXR-sulfhydration is a novel post-translational modification affected by hepatic endogenous CSE/H2S that may promote FXR activity and attenuate NAFLD. Hepatic CSE deficiency promotes development of non-alcoholic steatohepatitis. The interaction between H2S and FXR may be amenable to therapeutic drug treatment in NAFLD." @default.
- W4280554970 created "2022-05-22" @default.
- W4280554970 creator A5000769704 @default.
- W4280554970 creator A5004877322 @default.
- W4280554970 creator A5013553950 @default.
- W4280554970 creator A5013794662 @default.
- W4280554970 creator A5027886490 @default.
- W4280554970 creator A5030038857 @default.
- W4280554970 creator A5030865232 @default.
- W4280554970 creator A5041433782 @default.
- W4280554970 creator A5045555652 @default.
- W4280554970 creator A5047237529 @default.
- W4280554970 creator A5053943040 @default.
- W4280554970 creator A5067479144 @default.
- W4280554970 creator A5068254913 @default.
- W4280554970 creator A5071075382 @default.
- W4280554970 creator A5090673306 @default.
- W4280554970 creator A5091448543 @default.
- W4280554970 date "2022-06-30" @default.
- W4280554970 modified "2023-10-16" @default.
- W4280554970 title "Hepatocellular cystathionine γ lyase/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor" @default.
- W4280554970 cites W1848278480 @default.
- W4280554970 cites W1923290148 @default.
- W4280554970 cites W1966922165 @default.
- W4280554970 cites W1978921174 @default.
- W4280554970 cites W1983620925 @default.
- W4280554970 cites W1988012657 @default.
- W4280554970 cites W2005456200 @default.
- W4280554970 cites W2054847530 @default.
- W4280554970 cites W2057466000 @default.
- W4280554970 cites W2060795231 @default.
- W4280554970 cites W2066747053 @default.
- W4280554970 cites W2073876100 @default.
- W4280554970 cites W2077272512 @default.
- W4280554970 cites W2079250193 @default.
- W4280554970 cites W2106768039 @default.
- W4280554970 cites W2107720387 @default.
- W4280554970 cites W2122860085 @default.
- W4280554970 cites W2125876853 @default.
- W4280554970 cites W2130013233 @default.
- W4280554970 cites W2132089197 @default.
- W4280554970 cites W2140455030 @default.
- W4280554970 cites W2142690286 @default.
- W4280554970 cites W2148874440 @default.
- W4280554970 cites W2158609797 @default.
- W4280554970 cites W2163479927 @default.
- W4280554970 cites W2179954546 @default.
- W4280554970 cites W2204688218 @default.
- W4280554970 cites W2288398049 @default.
- W4280554970 cites W2293546533 @default.
- W4280554970 cites W2315432074 @default.
- W4280554970 cites W2512162166 @default.
- W4280554970 cites W2567977470 @default.
- W4280554970 cites W2588760275 @default.
- W4280554970 cites W2588823181 @default.
- W4280554970 cites W2605955022 @default.
- W4280554970 cites W2751009161 @default.
- W4280554970 cites W2765876014 @default.
- W4280554970 cites W2784043971 @default.
- W4280554970 cites W2900533762 @default.
- W4280554970 cites W2993083975 @default.
- W4280554970 cites W3010370531 @default.
- W4280554970 cites W3087323895 @default.
- W4280554970 cites W3103882166 @default.
- W4280554970 cites W3127294357 @default.
- W4280554970 cites W3181456162 @default.
- W4280554970 doi "https://doi.org/10.1002/hep.32577" @default.
- W4280554970 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35586979" @default.
- W4280554970 hasPublicationYear "2022" @default.
- W4280554970 type Work @default.
- W4280554970 citedByCount "9" @default.
- W4280554970 countsByYear W42805549702022 @default.
- W4280554970 countsByYear W42805549702023 @default.
- W4280554970 crossrefType "journal-article" @default.
- W4280554970 hasAuthorship W4280554970A5000769704 @default.
- W4280554970 hasAuthorship W4280554970A5004877322 @default.
- W4280554970 hasAuthorship W4280554970A5013553950 @default.
- W4280554970 hasAuthorship W4280554970A5013794662 @default.
- W4280554970 hasAuthorship W4280554970A5027886490 @default.
- W4280554970 hasAuthorship W4280554970A5030038857 @default.
- W4280554970 hasAuthorship W4280554970A5030865232 @default.
- W4280554970 hasAuthorship W4280554970A5041433782 @default.
- W4280554970 hasAuthorship W4280554970A5045555652 @default.
- W4280554970 hasAuthorship W4280554970A5047237529 @default.
- W4280554970 hasAuthorship W4280554970A5053943040 @default.
- W4280554970 hasAuthorship W4280554970A5067479144 @default.
- W4280554970 hasAuthorship W4280554970A5068254913 @default.
- W4280554970 hasAuthorship W4280554970A5071075382 @default.
- W4280554970 hasAuthorship W4280554970A5090673306 @default.
- W4280554970 hasAuthorship W4280554970A5091448543 @default.
- W4280554970 hasBestOaLocation W42805549702 @default.
- W4280554970 hasConcept C104317684 @default.
- W4280554970 hasConcept C126322002 @default.
- W4280554970 hasConcept C134018914 @default.
- W4280554970 hasConcept C16525657 @default.
- W4280554970 hasConcept C181199279 @default.
- W4280554970 hasConcept C185592680 @default.
- W4280554970 hasConcept C187566844 @default.